A flash of light turns graphene into a biosensor
Disease diagnosis, toxin detection and more are possible with DNA-graphene nanostructure
Tests showed that the fluorescence dimmed significantly when single-stranded DNA rested on graphene, but that double-stranded DNA only darkened slightly – an indication that single-stranded DNA had a stronger interaction with graphene than its double-stranded cousin. The researchers then examined whether they could take advantage of the difference in fluorescence and binding. When they added complementary DNA to single-stranded DNA-graphene structures, they found the fluorescence glowed anew. This suggested the two DNAs intertwined and left the graphene surface as a new molecule.
DNA's ability to turns its fluorescent light switch on and off when near graphene could be used to create a biosensor, the researchers propose. Possible applications for a DNA-graphene biosensor include diagnosing diseases like cancer, detecting toxins in tainted food and detecting pathogens from biological weapons. Other tests also revealed that single-stranded DNA attached to graphene was less prone to being broken down by enzymes, which makes graphene-DNA structures especially stable. This could lead to drug delivery for gene therapy. Tang will discuss this research and some of its possible applications in medicine, food safety and biodefense.
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.